Dong-A Socio Holdings Co., Ltd. (KRX:000640)
96,300
+4,100 (4.45%)
Last updated: Aug 28, 2026, 2:38 PM KST
Dong-A Socio Holdings Revenue
Dong-A Socio Holdings had revenue of 412.39B KRW in the quarter ending June 30, 2026, with 18.88% growth. This brings the company's revenue in the last twelve months to 1.52T, up 10.06% year-over-year. In the year 2025, Dong-A Socio Holdings had annual revenue of 1.43T with 7.24% growth.
Revenue (ttm)
1.52T
Revenue Growth
+10.06%
P/S Ratio
0.40
Revenue / Employee
18.29B
Employees
83
Market Cap
611.17B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.43T | 96.54B | 7.24% |
| Dec 31, 2024 | 1.33T | 201.23B | 17.78% |
| Dec 31, 2023 | 1.13T | 117.14B | 11.54% |
| Dec 31, 2022 | 1.01T | 132.92B | 15.07% |
| Dec 31, 2021 | 881.94B | 98.63B | 12.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Daewoong | 2.12T |
| Chong Kun Dang Pharmaceutical | 1.74T |
| Boryung | 1.06T |
| JW Holdings | 1.01T |
| Dong-A ST | 860.94B |
| JW Pharmaceutical | 820.86B |
| Huons | 616.80B |
| Ildong Pharmaceutical | 582.33B |